Bill
A 358
Bill A 358 allows pharmacists to dispense HIV prevention medications without a prescription, improving access for at-risk individuals and enhancing public health efforts.
Bill Number: A 358
Title: Authorizes pharmacists to dispense HIV pre-exposure and post-exposure prophylaxis
Status: Referred to Higher Education
Introduced: January 08, 2025
Classification: Bill
Bill A 358 aims to enhance public health measures by allowing licensed pharmacists to dispense HIV pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP). The intent of this legislation is to improve access to these critical medications, which are proven to significantly reduce the risk of HIV transmission among at-risk populations.
Pharmacist Authority: The bill grants pharmacists the authority to dispense PrEP and PEP without requiring a prior prescription from a physician. This change is designed to streamline access to these medications, making them more readily available to individuals who may benefit from them.
Training Requirements: Pharmacists will be required to undergo specific training to ensure they are knowledgeable about the medications, their usage, and the populations that would benefit from them. This training is crucial for maintaining safety and efficacy in dispensing these drugs.
Patient Education: The bill emphasizes the importance of patient education, requiring pharmacists to provide information on the proper use of PrEP and PEP, as well as counseling on HIV prevention strategies.
Insurance Coverage: While the bill does not directly address insurance coverage, it encourages the inclusion of PrEP and PEP in pharmacy benefit plans to ensure that cost does not become a barrier to access.
Pharmacists: This bill directly impacts pharmacists by expanding their scope of practice and allowing them to play a more active role in HIV prevention.
Patients at Risk of HIV: Individuals who are at high risk for HIV infection will benefit from increased access to PrEP and PEP, potentially leading to lower rates of new HIV infections.
Healthcare System: The healthcare system may experience a shift in how HIV prevention is approached, with pharmacists becoming key players in public health initiatives.
Current Status: As of January 08, 2025, Bill A 358 has been referred to the Higher Education committee for further consideration.
Related Legislation: This bill is related to several prior-session bills (A 9013, A 2198, A 5995) and has a companion bill in the Senate (S 7435), indicating ongoing legislative interest in expanding access to HIV prevention methods.
Bill A 358 represents a significant step towards improving access to HIV prevention medications through pharmacist involvement. By allowing pharmacists to dispense PrEP and PEP, the bill aims to reduce barriers to access and enhance public health outcomes for individuals at risk of HIV. The ongoing legislative process will determine the final provisions and implementation of this important public health initiative.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
